Kenvue Inc. $KVUE Shares Newly Bought by Mirae Asset Global Investments Co. Ltd.

Key Points

• Mirae Asset Global Investments opened a Kenvue position in the third quarter, buying 614,092 shares valued at approximately $10.8 million. Institutional investors collectively own 97.64% of the company’s shares.
• Analyst sentiment is broadly neutral: ten analysts rate Kenvue Hold, with a consensus price target of $19.29. The stock opened at $19.31.
• Kenvue reported quarterly EPS of $0.29, in line with estimates, and revenue of $3.89 billion, slightly above expectations and up 3.2% year over year. Its annualized dividend is $0.84 per share, a 4.4% yield.

Mirae Asset Global Investments Co. Ltd. bought a new stake in Kenvue Inc. (NYSE:KVUE - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 614,092 shares of the company's stock, valued at approximately $10,845,000.

Other large investors have also modified their holdings of the company. Johnson Financial Group Inc. purchased a new position in Kenvue in the second quarter valued at approximately $26,000. GK Wealth Management LLC acquired a new position in Kenvue during the third quarter worth about $27,000. CoreCap Advisors LLC boosted its position in Kenvue by 64.9% during the second quarter. CoreCap Advisors LLC now owns 1,502 shares of the company's stock worth $29,000 after purchasing an additional 591 shares in the last quarter. Bell Investment Advisors Inc purchased a new position in shares of Kenvue during the 2nd quarter worth approximately $35,000. Finally, Keating Financial Advisory Services Inc. acquired a new stake in shares of Kenvue during the second quarter valued at $38,000. Hedge funds and other institutional investors own 97.64% of the company's stock.

Analyst Upgrades and Downgrades

KVUE has been the subject of a number of research reports. Weiss Ratings reiterated a "hold (c)" rating on shares of Kenvue in a report on Friday, September 11th. Wall Street Zen cut Kenvue from a "buy" rating to a "hold" rating in a report on Saturday, August 8th. Barclays lifted their price objective on shares of Kenvue from $18.00 to $19.00 and gave the company an "equal weight" rating in a research note on Tuesday, July 21st. UBS Group raised their price target on shares of Kenvue from $19.00 to $20.00 and gave the company a "neutral" rating in a report on Monday. Finally, HSBC cut their price objective on shares of Kenvue from $20.00 to $19.00 and set a "hold" rating on the stock in a report on Monday, August 10th. Ten investment analysts have rated the stock with a Hold rating. Based on data from MarketBeat, Kenvue currently has an average rating of "Hold" and a consensus price target of $19.29.

Kenvue Stock Performance

NYSE:KVUE opened at $19.31 on Thursday. The company has a 50-day moving average of $18.41 and a 200-day moving average of $18.22. The firm has a market cap of $37.09 billion, a price-to-earnings ratio of 21.94, a price-to-earnings-growth ratio of 1.77 and a beta of 0.48. The company has a current ratio of 1.01, a quick ratio of 0.71 and a debt-to-equity ratio of 0.67. Kenvue Inc. has a twelve month low of $14.06 and a twelve month high of $20.13.

Kenvue (NYSE:KVUE - Get Free Report) last announced its quarterly earnings data on Friday, October 30th. The company reported $0.29 EPS for the quarter, meeting analysts' consensus estimates of $0.29. The company had revenue of $3.89 billion during the quarter, compared to the consensus estimate of $3.86 billion. Kenvue had a return on equity of 21.22% and a net margin of 10.76%. The company's quarterly revenue was up 3.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.28 EPS. Analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 2nd. Investors of record on Monday, September 21st were paid a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a dividend yield of 4.4%. The ex-dividend date of this dividend was Monday, September 21st. Kenvue's dividend payout ratio (DPR) is presently 95.45%.

Kenvue Company Profile

Kenvue Inc is a consumer health company that develops, markets and sells products designed to support everyday health and personal care. Its portfolio spans over-the-counter medicines, skin health and beauty, and essential health products, serving consumers through retail, e-commerce and other distribution channels.

The company's brands include Tylenol, Motrin, Zyrtec and Benadryl in self-care; Neutrogena, Aveeno and Clean & Clear in skin health and beauty; and Listerine, Johnson's and OGX in oral care, baby care and hair care.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.